Slide 1Nuovi farmaci antitrombotici: che cosa cambierà in clinica nei prossimi anni? GF Gensini Livorno 27 marzo 2004 Slide 2 Currently available anticoagulants: largely…

Slide 1Allison Weddington, PharmD PGY1 Pharmacy Resident St. Louis Childrens Hospital November 14, 2011 How Much is Too Much? The Use of Rasburicase in the Treatment of Tumor…

Slide 1What is MDS MDS comprises a heterogeneous group of clonal haematopoietic stem cell malignancies characterised by 1,2 –BM dysplasia hypercellular BM is present in…

Slide 1Red cells from Cord Blood - a new product for the Blood Bank?? Elisabeth Semple, PhD Scientific Director Cells for Life Cord Blood Institute Toronto Slide 2 Learning…

Slide 1Your Approach to Heart failure and Arrhythmias in Diabetics Dr Mervat Aboulmaaty Professor of Cardiology Ain Shams University 2012 Slide 2 DIAGNOSIS OF HEART FAILURE…

Page 1 Neutropénie fébrile Dr S. Alfandari Infectiologue et Hygiéniste, CH Tourcoing Infectiologue du Service des Maladies du sang, CHRU Lille Dr S. Alfandari Infectiologue…

1. When, How, and What Cell Source for Transplantation in ALL CR1 Hillard M. Lazarus, MD, FACP Professor of Medicine Director of Novel Cell Therapies University Hospitals…

1. Nutritional Counseling and Dietetics Practice in Sickle Cell DiseaseNutrition and Hemoglobinopathies Working GroupAugust 24, 2010Jean Ann Olds MS RDDirector, TCH Clinical…

1. Fungal infections in hematology patients: advances in prophylaxis and treatment Vincent CC Cheng MBBS (HK), MD (HK), PDipID (HK), MCRP (UK), FRCPath (UK), FHKCPath, FHKAM…

1. Is there anything new for relapsed AML? Steven M. Kornblau, M.D. Department of Leukemia Department of Stem Cell Transplantation and Cellular Therapy 2. The Status Quo…